Jove
Visualize
联系我们

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

201
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

76
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
76
Cancer Survival Analysis01:21

Cancer Survival Analysis

384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same journal

Survey of the intersection of mental maps and visualization.

Visual computing for industry, biomedicine, and art·2026
Same journal

ZACP: enhancing skin lesion classification ability using zero attention and complete perception.

Visual computing for industry, biomedicine, and art·2026
Same journal

CRR-Net: a correlation reconstruction and refinement network for deformable medical image registration.

Visual computing for industry, biomedicine, and art·2026
Same journal

Foundation model for screening severe mitral regurgitation and severe aortic stenosis from coronary angiograms.

Visual computing for industry, biomedicine, and art·2026
Same journal

Multiscale feature fusion for few-shot medical image learning with fisher information-driven layer selection.

Visual computing for industry, biomedicine, and art·2026
Same journal

MEDI-SLATE: medical imaging slide-lecture aligned teaching ensemble.

Visual computing for industry, biomedicine, and art·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 20, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

对心血管疾病数据驱动的预后系统进行超参数优化.

Jayson Saputra1, Cindy Lawrencya2, Jecky Mitra Saini2

  • 1Industrial Engineering Department, BINUS Graduate Program - Master of Industrial Engineering, Bina Nusantara University, Jakarta 11480, Indonesia. jayson@binus.ac.id.

Visual computing for industry, biomedicine, and art
|July 31, 2023
PubMed
概括

预测心血管疾病 (CVD) 是非常重要的. 这项研究使用了机器学习模型,发现随机梯度下降 (SGD) 和人工神经网络 (ANN) 在心血管疾病风险预测中取得了高精度.

关键词:
心血管疾病是什么心血管疾病数据挖掘是一种数据挖掘.数据驱动分析数据驱动分析超参数优化超参数优化色数据挖掘软件 是一个数据挖掘软件.预测系统的预测系统无监督的机器学习

更多相关视频

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

相关实验视频

Last Updated: Jul 20, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

科学领域:

  • 心血管疾病的研究研究.
  • 医疗数据挖掘是如何进行的
  • 机器学习在医疗保健中的应用

背景情况:

  • 心血管疾病 (CVD) 是全球死亡的主要原因,需要改进预测和诊断方法.
  • 及时预后,考虑到患者病史和生活方式,是预防和管理心血管疾病的关键.
  • 在现代医学中,利用患者数据集进行心血管疾病风险因素分析是一个重大挑战.

研究的目的:

  • 应用数据挖掘和无监督机器学习技术来分析心血管疾病预后数据集.
  • 评估各种用于CVD预测的机器学习模型的性能和分类准确性.
  • 使用集群方法,确定心血管疾病患者数据中的最佳集群数量.

主要方法:

  • 使用Orange软件对918名成年患者 (28-77岁) 的数据集进行数据挖掘.
  • 利用监督学习算法,包括k-最近的邻居,支持向量机,随机森林,人工神经网络 (ANN), naive bayes,后勤回归,随机梯度下降 (SGD) 和AdaBoost.
  • 应用无监督的集群方法,如k-means,层次和基于密度的应用程序与噪声的空间集群 (DBSCAN),以识别数据模式.

主要成果:

  • 随机梯度下降 (SGD) 和人工神经网络 (ANN) 模型表现出最高的性能,达到0.900的分类精度.
  • K-means和等级聚类方法表明,心血管疾病预后数据集可以有效地被分为两个不同的集群.
  • 该研究强调了模型准确性与心血管疾病风险预测效率之间的强烈相关性.

结论:

  • SGD和ANN是高效的模型,可以非常准确地预测心血管疾病风险.
  • 将患者数据分为两组的聚类表明,可能存在明显的风险分层.
  • 准确的预测模型对于改善诊断能力和使心血管疾病及时进行预防性干预至关重要.